Expression of serum microRNA-378 and its clinical significance in renal cell carcinoma
AUTOR(ES)
Shi, Lixin, Zhang, Lei, Wang, Chunyang, Sun, Shengkun, Cao, Xiyuan, Zhang, Xu
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
2017-06
RESUMO
Abstract Studies have demonstrated that miRNA-378 is expressed in various malignant tumors. In the present study, we aimed to explore the expression of serum miRNA-378 and its clinical significance in renal cell carcinoma (RCC) patients. A total of 75 RCC patients, 63 renal cysts (RC) patients and 75 healthy controls were selected. The miRNA-378 level in RCC and RC groups was significantly higher than in healthy control group, with RCC group having the highest level. The miRNA-378 levels were significantly decreased within the same group after surgery. When compared with healthy controls, RC group had higher levels but not significantly (p > 0.05) while levels in RCC group were significantly higher (p < 0.05). miRNA-378 expression was correlated with clinical stage and differentiation degree, but not correlated with patient's age, gender, surgical strategy and tumor diameter. The AUC of miRNA-378 was 0.896, 95% confidence interval was 0.847 to 0.945, and AUC hypothesis testing was statistically significant (p < 0.001, RCC vs healthy control). miRNA-378 shows potential in the diagnosis and prediction of postoperative curative effect of renal cell carcinoma, but further studies with lager samples are needed.
Documentos Relacionados
- Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer
- Clinical significance and correlation of microRNA-21 expression and the neutrophil-lymphocyte ratio in patients with acute myocardial infarction
- Analysis of serum microRNA expression in male workers with occupational noise-induced hearing loss
- Patterns of microRNA expression characterize stages of human B-cell differentiation
- MicroRNA Expression Signature and the Role of MicroRNA-21 in the Early Phase of Acute Myocardial Infarction*